Skip to main content
VCbacked
Log inGet Started

Effector Therapeutics

San Diego, United States

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

$15.0M raised
Jan 2024
Post-IPO Equity
BiotechnologyHealth CareMedical

Top Investors

AbbVieU.S. Venture PartnersThe Column GroupAbingworthSR One

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Effector Therapeutics

How much funding has Effector Therapeutics raised?
Effector Therapeutics has raised $15.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.
Who are Effector Therapeutics's investors?
Effector Therapeutics's investors include AbbVie, U.S. Venture Partners, The Column Group, Abingworth, SR One.
Where is Effector Therapeutics headquartered?
Effector Therapeutics is headquartered in San Diego, United States.
What does Effector Therapeutics do?
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
What stage is Effector Therapeutics at?
Effector Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Effector Therapeutics — Funding & Investors." VCBacked, January 25, 2024, https://www.vcbacked.co/company/effector-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2024). Effector Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/effector-therapeutics
Wikipedia (cite web)
{{cite web |title=Effector Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/effector-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K